161 related articles for article (PubMed ID: 22001541)
1. Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.
Ohsawa M; Kato K; Tanno K; Itai K; Fujishima Y; Okayama A; Turin TC; Onoda T; Suzuki K; Nakamura M; Kawamura K; Akiba T; Sakata K; Fujioka T
J Epidemiol; 2011; 21(6):491-9. PubMed ID: 22001541
[TBL] [Abstract][Full Text] [Related]
2. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.
Ohsawa M; Kato K; Itai K; Tanno K; Fujishima Y; Konda R; Okayama A; Abe K; Suzuki K; Nakamura M; Onoda T; Kawamura K; Sakata K; Akiba T; Fujioka T
J Epidemiol; 2010; 20(1):30-9. PubMed ID: 19881229
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
Fabrizi F; Dixit V; Messa P
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):244-254. PubMed ID: 30910601
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy.
Nakayama E; Akiba T; Marumo F; Sato C
J Am Soc Nephrol; 2000 Oct; 11(10):1896-1902. PubMed ID: 11004221
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.
Gohar SA; Khalil RY; Elaish NM; Khedr EM; Ahmed MS
J Egypt Public Health Assoc; 1995; 70(5-6):465-84. PubMed ID: 17214170
[TBL] [Abstract][Full Text] [Related]
6. Risk of death among chronic dialysis patients infected with hepatitis C virus.
Stehman-Breen CO; Emerson S; Gretch D; Johnson RJ
Am J Kidney Dis; 1998 Oct; 32(4):629-34. PubMed ID: 9774125
[TBL] [Abstract][Full Text] [Related]
7. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
[TBL] [Abstract][Full Text] [Related]
8. Serum selenium levels are inversely associated with death risk among hemodialysis patients.
Fujishima Y; Ohsawa M; Itai K; Kato K; Tanno K; Turin TC; Onoda T; Endo S; Okayama A; Fujioka T
Nephrol Dial Transplant; 2011 Oct; 26(10):3331-8. PubMed ID: 21372251
[TBL] [Abstract][Full Text] [Related]
9. Superinfection with hepatitis C virus in hemodialysis patients with hepatitis B surface antigenemia: its prevalence and clinical significance in Taiwan.
Chen KS; Lo SK; Lee N; Leu ML; Huang CC; Fang KM
Nephron; 1996; 73(2):158-64. PubMed ID: 8773337
[TBL] [Abstract][Full Text] [Related]
10. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
[TBL] [Abstract][Full Text] [Related]
11. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
[TBL] [Abstract][Full Text] [Related]
12. Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
Park H; Jeong D; Nguyen P; Henry L; Hoang J; Kim Y; Sheen E; Nguyen MH
PLoS One; 2018; 13(4):e0196452. PubMed ID: 29708985
[TBL] [Abstract][Full Text] [Related]
13. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Aljama P
Nephrol Dial Transplant; 2001 Aug; 16(8):1669-74. PubMed ID: 11477172
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
[TBL] [Abstract][Full Text] [Related]
15. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P
J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.
Okino K; Okushi Y; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
Clin Exp Nephrol; 2017 Dec; 21(6):1113-1123. PubMed ID: 28357506
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients.
Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L
Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548
[TBL] [Abstract][Full Text] [Related]
18. [Detection of hepatitis C virus antigen in hemodialysis patients].
Wu RH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):232-4. PubMed ID: 20104788
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon.
Halle MP; Choukem SP; Kaze FF; Ashuntantang G; Tchamago V; Mboue-Djieka Y; Temfack E; Luma HN
Iran J Kidney Dis; 2016 Sep; 10(5):304-309. PubMed ID: 27721229
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
